Senior/ Principal Manager Central Imaging*
Immatics Biotechnologies
This listing was originally posted on Immatics Biotechnologies's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moOVERVIEW
We are currently seeking a Principal Manager Central Imaging* to strengthen our Clinical Sciences team in the clinical development of innovative cancer immunotherapeutic products. You will work in an interdisciplinary environment with internal colleagues and external imaging vendors and will contribute to our mission of delivering novel PRAME immunotherapies to patients with cancer.
The position can be filled in Tübingen, Munich or remote within Germany and is offered on a fixed-term contract for 24 months.
YOUR MISSION
You will independently manage central imaging activities for assigned global oncology trials and contribute scientific expertise to imaging endpoints and response assessments. Your main responsibilities will include but are not limited to the following tasks:
YOUR PROFILE
You hold an MSc, PharmD or preferably a PhD in Life Sciences, Medicine, Pharmacy or a related field and bring 4+ years of experience in clinical development, clinical trial management and central imaging in oncology. You have expertise in BICR processes, CT/MRI/PET imaging, RECIST 1.1 and iRECIST, as well as managing imaging vendors and operations in global clinical trials. Experience in late-stage oncology, immuno-oncology, T-cell therapies or T-cell-engaging bispecifics is highly desirable.
You possess strong knowledge of ICH-GCP and clinical imaging requirements and can assess imaging data and processes, identify risks and implement effective solutions. Experience with regulatory submissions, audits and inspections is a plus.
You are an independent, analytical and collaborative professional with excellent English communication skills (German is considered an advantage) who thrives in a dynamic environment. A structured, proactive mindset, strong ownership and a passion for improving outcomes for patients with cancer complete your profile.
WHY US?
We are the global leader in precision targeting of PRAME. Driven by our mission to make an impact on the lives of patients with cancer, we are a committed and inspired team and cherish the collegial, highly motivated, and family-friendly atmosphere within Immatics. We offer an innovative and collaborative environment where employees are empowered to contribute to groundbreaking cancer therapies and further their professional growth. To support their well-being, we provide opportunities for continuous learning, a company-sponsored pension scheme, childcare support, and our flexible “Two Out of Three” benefits concept, which allows employees to receive subsidies for two of the following options: EGYM Wellpass, JobRad, and JobTicket.
NOTICE
*We value diversity and inclusion. Immatics N.V. and all Immatics subsidiaries are equal opportunity employers that evaluate qualified applicants without regard to race, color, national origin, religion, sex, age, marital status, disability, veteran status, sexual orientation, gender identity, or other characteristics protected by law.
ABOUT IMMATICS
Immatics is committed to making a meaningful impact on the lives of patients with cancer. We are the global leader in precision targeting of PRAME, a target expressed in more than 50 cancers. Our cutting-edge science and robust clinical pipeline form the broadest PRAME franchise with the most PRAME indications and modalities, spanning TCR T-cell therapies and TCR bispecifics.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Immatics Biotechnologies?
Help others prepare — share your experience anonymously.
BIOTECHNOLOGY
Personalized T-cell Directed Immunotherapies
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo